Hyperphosphatemia, hyperparathyroidism, high levels of fibroblast growth factor-23 (FGF-23), low levels of 1,25-dihydroxyvitamin D (calcitriol), and hypocalcemia characterize patients with advanced CKD and ESRD [14,15]. This evidence concerns the gene FGF23 and chronic kidney disease.